Live Breaking News & Updates on Global Oncology Cell|Page 1

Stay updated with breaking news from Global oncology cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 | The Kingston Whig Standard

Philadelphia, Pennsylvania and Oxford, United Kingdom (Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), ....

Sao Paulo , United States , United Kingdom , Dana Lynch , Cintia Piccina , Julip Miller , Adrian Rawcliffe , Exchange Commission , Postmedia Network Inc , Drug Administration , Gene Strategy Program Management Office , Company Sarcoma Franchise , Corporate Communications , University Of Sao Paulo , Newsfile Corp , Corporate Affairs , Adaptimmune Hires Chief Commercial Officer , Late Stage Product , Chief Commercial Officer , Adaptimmune Therapeutics , Chief Executive Officer , Postmedia Network , Kingston Whig Standard , Noon News Roundup , Viral Specifict Cell , Bluebird Bio ,

Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise

Cintia Piccina returns as Chief Commercial Officer effective March 18, 2024 Philadelphia, Pennsylvania and Oxford, United Kingdom (Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced the reappointment of Cintia Piccina as Chief Commercial Officer effective March 18, 2024. Cintia served in this role from January 2022 to March 2023. Cintia will lead a rapidly expanding comme ....

United States , Sao Paulo , Cintia Piccina , Dana Lynch , Julip Miller , Adrian Rawcliffe , United Newsfile Corp , Corporate Communications , Gene Strategy Program Management Office , Drug Administration , Exchange Commission , Corporate Affairs , University Of Sao Paulo , Chief Commercial Officer , Chief Executive Officer , Viral Specifict Cell , Bluebird Bio , Global Oncology Cell , Gene Strategy , Program Management Office , Escola Superior De Propaganda , Biologics License Application , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,

Form 8-K Adaptimmune Therapeutics For: Feb 26

Form 8-K Adaptimmune Therapeutics For: Feb 26
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sao Paulo , United States , Company For , Gene Strategy Program Management Office , Company American Depositary , University Of Sao Paulo , Company Board Of Directors The , Certain Officers , Compensatory Arrangements , Cintia Piccina , Chief Commercial Officer , Employment Agreement , Annual Bonus , Business Expenses , Transition Business Expenses Payments , Transition Business Expenses Period , Relocation Payment , Good Reason , American Depositary Shares , Revised Exercise Period , Revised Exercise , Viral Specifict Cell , Global Oncology Cell , Gene Strategy , Program Management , Escola Superior De Propaganda ,

AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer

- Industry veteran brings more than 25 years of global commercial leadership and cell therapy expertise to AlloVir to build out company s commercial strategy and capabilities -

. | May 16, 2023 ....

Sao Paulo , Cintia Piccina , Diana Brainard , Gene Strategy Program Management Office , University Of Sao Paulo , Chief Commercial Officer , Chief Executive Officer , Adaptimmune Therapeutics , Global Oncology Cell , Gene Strategy , Program Management Office , Escola Superior De Propaganda , Nc Stock Exchange , Press Release , Apabilities Alvr Us0198181036 ,

Adaptimmune Announces Appointment of Cintia Piccina as

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. 26, 2022 (GLOBE NEWSWIRE) Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to. ....

Sao Paulo , United Kingdom , United States , Adrian Rawcliffe , Julip Miller , Exchange Commission , Gene Strategy Program Management Office , University Of Sao Paulo , Corporate Affairs , Cintia Piccina , Chief Commercial Officer , Chief Executive , Global Oncology Cell , Gene Strategy , Program Management Office , Escola Superior De Propaganda , Specific Peptide Enhanced Affinity Receptor , Private Securities Litigation Reform Act , Quarterly Report , Investor Relations , Nasdaq Adap , Adaptimmune Therapeutics Plc ,